Compare CACI & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CACI | ICLR |
|---|---|---|
| Founded | 1962 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 9.3B |
| IPO Year | 2007 | 2001 |
| Metric | CACI | ICLR |
|---|---|---|
| Price | $469.54 | $176.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 13 |
| Target Price | ★ $689.50 | $178.62 |
| AVG Volume (30 Days) | 265.1K | ★ 1.1M |
| Earning Date | 04-22-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | ★ 17.11 | N/A |
| Revenue | ★ $4,467,860,000.00 | N/A |
| Revenue This Year | $12.42 | N/A |
| Revenue Next Year | $10.00 | N/A |
| P/E Ratio | $27.26 | ★ $12.91 |
| Revenue Growth | ★ 2.60 | N/A |
| 52 Week Low | $434.70 | $66.57 |
| 52 Week High | $683.50 | $211.00 |
| Indicator | CACI | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 42.24 | 76.43 |
| Support Level | $434.70 | $174.63 |
| Resistance Level | $511.94 | $193.87 |
| Average True Range (ATR) | 19.23 | 7.72 |
| MACD | -2.69 | 2.28 |
| Stochastic Oscillator | 34.68 | 88.32 |
CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.